The anorectic effects of GLP-1 make it a valuable target for obesity treatments[^3^]
Centers for Medicare and Medicaid Services (CMS) has announced that semaglutide, Novo Nordisks obesity drug sold under the brand name Wegovy, will be covered by Medicare if prescribed for its heart health benefits
If these symptoms occur, imaging studies such as ultrasound may be needed to evaluate the gallbladder
Its anxiolytic potential operates through a completely different pathway: the reduction of systemic inflammation that drives neuroinflammation and, consequently, anxiety
Release liner can be of Paper fabric, Polyethylene, Polyvinylchloride, Polyester foil and Metalized laminate
Budgeting for the new therapy remains a huge challenge, but with emerging evidence and pricing dynamics, plan sponsors should revisit older cost-benefit analyses